UPenn Perelman School of Medicine: Common Medication for Autoimmune Diseases Works on Giant Cell Arteritis
June 26, 2025
June 26, 2025
PHILADELPHIA, Pennsylvania, June 26 (TNSjou) -- The University of Pennsylvania's Perelman School of Medicine issued the following news release:
* * *
Common medication for autoimmune diseases works on giant cell arteritis
Treatment with upadacitinib, a JAK inhibitor, resulted in sustained remission for almost half of the clinical trial patients.
*
A common medication already used for autoimmune diseases such as rheumatoid arth . . .
* * *
Common medication for autoimmune diseases works on giant cell arteritis
Treatment with upadacitinib, a JAK inhibitor, resulted in sustained remission for almost half of the clinical trial patients.
*
A common medication already used for autoimmune diseases such as rheumatoid arth . . .